A Study of Modified mRNA Vaccines in Healthy Adults

Conditions:   SARS-CoV-2;   Seasonal Influenza;   Respiratory Syncytial Virus;   Cytomegalovirus Interventions:   Biological: mRNA-1273;   Biological: mRNA-1010;   Biological: mRNA-1345;   Biological: FLUAD®;   Biological: mRNA-1647 Sponsor:   ModernaTX, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials